TBPL is pleased to announce the launch of its latest product, THURISAVE-24.
Tanzania Biotech Products Limited (TBPL) was established in 2015 As a subsidiary company of National Development Corporation (NDC) whereby Tanzania Government is the main shareholder. The plant is located along TAMCO Industrial Estate at Kibaha, Pwani Region. Tanzania Biotech Products Limited is the producer of Biolarvicides and Biopesticides commercially known as BACTIVE,GRISELESF® and THURISAVE-24
These products are effective integration with environmental health programmes to control diseases transmitted to man by mosquitoes, since it eliminate the larvae they prevent the emergence of adult insects, which are the direct agents of the transmission of the illnesses to man. And that is among the objectives of establishing the plant, is to develop a biolarvicides for scaling up of the larviciding programme for eradicating malaria in Tanzania and Africa country as general. The products control mosquito larvae in stages I-III and the beginning of stage IV, through ingestion.
To become the leading producer of environmentally friendly bioproducts in Africa.
To produce quality bioproducts for sustainable use in the health and agricultural sectors while upholding ethical and professional values and meeting customer needs.
TBPL is producing two types of Biolarvicides products,and one Biopesticide commercially known as Bactivec®, Griselesf® and Thurisave-24. These products have been effectively used in different parts of the world apart from Tanzania and Africa, others are Latin America and Asia. They have been used to successfully combat disease-bearing mosquitoes both preventively and as parts of integrated control programmes. They have also proved useful in epidemics of serious illnesses such as Yellow Fever, Dengue, Malaria, Human Filariasis, various types of Encephalitis and Onchocerciasis or River Blindness. They are also used to control infestations of other species of blood feeding diptera, whose bites cause discomfort to man both in communities and tourist areas It’s a modern technology of fight against the malaria vector while preventing natural resources.
Bactivec® is produced using bacterial strains called Bacillus thuringiensis serotype H-14, strain266/2
Read MoreGriselesf® respectively is produced using bacterial strains called Bacillus sphaericus strain 2362.
Thurisave-24 is produced using bacterial strains called Bacillus thuringiensis kurstaki
It’s a modern technology of fight against the malaria vector while preventing natural resources.
The products are environmental friendly and highly specific for Mosquito larvae.
Highly effective control of the larvae of different species of mosquito in urban, rural, industrial and tourist development areas, and under the most varied climates and application conditions;
Totally harmless effects on other animal and plant species present in the various aquatic habitats where mosquitoes develop
Effective integration with environmental health programmes to control diseases transmitted to man by mosquitoes.
Just one application kills mosquito larvae in stages I-III and the beginning of stage IV, through ingestion.